Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

HARMONY BIOSCIENCES HOLDINGS, INC.

(HRMY)
  Report
Delayed Nasdaq  -  04:00:00 2023-05-26 pm EDT
35.56 USD   -1.19%
05/26Harmony Biosciences : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
05/25Harmony biosciences completes enrollment of phase 3 registrational intune study in idiopathic hypersomnia
PR
05/25Harmony Biosciences Holdings, Inc. Completes Enrollment of Phase 3 Registrational Intune Study in Idiopathic Hypersomnia
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about HARMONY BIOSCIENCES HOLDINGS, INC.
05/26Harmony Biosciences : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
05/25Harmony biosciences completes enrollment of phase 3 registrational intune study in idio..
PR
05/25Harmony Biosciences Holdings, Inc. Completes Enrollment of Phase 3 Registrational Intun..
CI
05/11Harmony biosciences to present new wakix safety and efficacy data at sleep 2023 annual ..
AQ
05/10Harmony biosciences to present new wakix« (pitolisant) safety and efficacy data at slee..
PR
05/10Harmony Biosciences Holdings, Inc. to Present New WAKIXáSafety and Efficacy Data
CI
05/03Cantor Fitzgerald Adjusts Price Target on Harmony Biosciences Holdings to $75 From $71,..
MT
05/02Harmony Biosciences' Q1 Non-GAAP Earnings, Revenue Rise; Shares Soar
MT
05/02Transcript : Harmony Biosciences Holdings, Inc., Q1 2023 Earnings Call, May 0..
CI
05/02Harmony Biosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended..
CI
05/02Harmony Biosciences : HRMY Q1 23 Earnings Presentation FINAL
PU
05/02Harmony Biosciences Holdings, Inc. Appoints Kumar Budur as Chief Medical Officer
CI
05/02Earnings Flash (HRMY) HARMONY BIOSCIENCES Reports Q1 EPS $0.48, vs. Street Est of $0.46
MT
05/02Harmony Biosciences Reports First Quarter 2023 Financial Results and Business Updates
GL
04/25Harmony Biosciences Holdings, Inc. Appoints Jeffrey M. Dayno, M.D. as Chief Executive O..
CI
04/25Harmony Biosciences Holdings, Inc. Appoints Jeffrey M. Dayno, M.D. as President
CI
04/25Harmony biosciences announces jeffrey m. dayno, m.d. appointed president and chief exec..
AQ
04/24Harmony Biosciences Names Jeffrey Dayno as President, Chief Executive
MT
04/24Harmony biosciences announces jeffrey m. dayno, m.d. appointed president & chief execut..
PR
04/20Harmony biosciences to report first quarter 2023 financial results on may 2, 2023
PR
04/20BofA Securities Initiates Coverage on Harmony Biosciences With Neutral Rating, $35 Pric..
MT
03/29Sector Update: Health Care Stocks Steady Late Wednesday
MT
03/29Sector Update: Health Care Stocks Mixed on Wednesday Afternoon
MT
03/29Harmony Biosciences Says Patient Enrollment in Late-Stage Idiopathic Hypersomnia Trial ..
MT
03/29Harmony Biosciences Says Patient Enrollment in Late-Stage Idiopathic Hypersomnia Trial ..
MT
03/29Hony Biosciences Holdings, Inc. Accelerates the Timeline for Completion of Phase 3 Inte..
CI
03/29Harmony biosciences announces accelerated timeline for phase 3 intune study in idiopath..
PR
03/28Top Midday Decliners
MT
03/28Harmony Biosciences Disputes Assertions in Scorpion Capital Short Seller Report on Dayt..
MT
03/28Harmony Biosciences Shares Fall on Scorpion Capital Short Seller Report on Daytime Slee..
MT
03/28Harmony Biosciences Falls Past 26% After Scorpion Capital Issues Short Report, Seeks US..
MT
03/06Harmony biosciences to participate in upcoming investor conferences
PR
02/28Harmony biosciences continues community commitment in 2023 with patients at the heart a..
PR
02/22Goldman Sachs Adjusts Price Target on Harmony Biosciences Holdings to $43 From $49, Mai..
MT
02/22Needham Trims Price Target on Harmony Biosciences Holdings to $67 From $70, Keeps Buy R..
MT
02/22Mizuho Adjusts Price Target on Harmony Biosciences to $60 From $70, Reiterates Buy Rati..
MT
02/21Transcript : Harmony Biosciences Holdings, Inc., Q4 2022 Earnings Call, Feb 2..
CI
02/21Harmony Biosciences' Q4 Adjusted Net Income, Revenue Rise
MT
02/21Harmony Biosciences Holdings, Inc. Reports Earnings Results for the Full Year Ended Dec..
CI
02/21Harmony Biosciences : HRMY Q4 FY 22 Earnings Presentation FINAL
PU
02/21Harmony Biosciences Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ende..
CI
02/21Earnings Flash (HRMY) HARMONY BIOSCIENCES Posts Q4 EPS $0.79, vs. Street Est of $0.57
MT
02/21Harmony Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Bus..
GL
02/20Harmony biosciences certified as a great place to work for fifth consecutive year
AQ
02/17Harmony biosciences certified as a great place to work« for fifth consecutive year
PR
02/07Harmony biosciences to report fourth quarter and full year 2022 financial results on fe..
PR
01/11Transcript : Harmony Biosciences Holdings, Inc. Presents at 41st Annual J.P. ..
CI
01/10MarketScreener's World Press Review: January 10
MS
01/10North American Morning Briefing: More Hawkish Fed -2-
DJ
01/09Sector Update: Health Care Stocks Largely Struggle Monday
MT
01/09Sector Update: Health Care
MT
01/09Novavax's longtime CEO Stanley Erck to retire
RE
01/09Novavax Appoints John Jacobs as CEO
MT
01/09Harmony biosciences appoints jeffrey dayno, md as interim ceo and expands role of jeff ..
AQ
01/09Novavax's longtime CEO Stanley Erck to retire
RE
01/09Novavax CEO Stanley Erck to retire
RE
01/09North American Morning Briefing: 'Soft Landing' Rally Lo..
DJ
01/09Harmony Biosciences Names Jeffrey Dayno Interim Chief Executive as John Jacobs Steps Do..
MT
01/06Harmony biosciences appoints jeffrey m. dayno, md as interim ceo and expands role of je..
PR
01/06Harmony Biosciences Holdings, Inc. Announces Management Changes
CI
01/06Harmony Biosciences Holdings, Inc. Announces CEO Changes
CI
01/06Harmony Biosciences : HRMY 2023 JP Morgan Conference Presentation FINAL 1.5.23
PU
01/04Piper Sandler Adjusts Harmony Biosciences Holdings Price Target to $70 From $62, Mainta..
MT
2022Harmony biosciences to present at the 41st annual j.p. morgan healthcare conference
PR
2022Insider Sell: Harmony Biosciences Holdings
MT
2022Insider Sell: Harmony Biosciences Holdings
MT
2022Insider Sell: Harmony Biosciences Holdings
MT
2022Insider Sell: Harmony Biosciences Holdings
MT
2022Insider Sell: Harmony Biosciences Holdings
MT
2022Insider Sell: Harmony Biosciences Holdings
MT
2022Insider Sell: Harmony Biosciences Holdings
MT
2022HARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 34th ANNUAL HEALTHCARE CONFERENCE
PR
2022Mizuho Adjusts Price Target on Harmony Biosciences Holdings to $70 From $60, Maintains ..
MT
2022Insider Sell: Harmony Biosciences Holdings
MT
2022Insider Sell: Harmony Biosciences Holdings
MT
1  2  3  4  5Next
Upcoming event on HARMONY BIOSCIENCES HOLDINGS, INC.
-40% off: Our subscriptions help you unlock hidden opportunities!
Subscribe
fermer